A new role for an old drug: acetazolamide in decompensated heart failure
- 28 December 2022
- journal article
- research article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 24 (3) , 309-313
Abstract
Mortality from heart failure remains high. Many subjects who have been hospitalised with acute decompensated heart failure leave hospital with residual congestion, despite treatment with loop diure...Keywords
This publication has 13 references indexed in Scilit:
- Effects of Metolazone Administration on Congestion, Diuretic Response and Renal Function in Patients with Advanced Heart FailureJournal of Clinical Medicine, 2021
- Epidemiology of Heart FailureCirculation Research, 2021
- Effect of Empagliflozin as an Add-On Therapy on Decongestion and Renal Function in Patients With Diabetes Hospitalized for Acute Decompensated Heart FailureCirculation: Heart Failure, 2021
- Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE‐HF trialDiabetes, Obesity and Metabolism, 2021
- Comparison of Changes in Plasma Volume and Renal Function between Acetazolamide and Conventional Diuretics: Understanding the Mechanical Differences according to the “Chloride Theory”Cardiology, 2019
- Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational studyBMC Cardiovascular Disorders, 2019
- Acetazolamide to Increase Natriuresis in Congestive Heart Failure at High Risk for Diuretic ResistanceEuropean Journal of Heart Failure, 2019
- Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart FailureCirculation: Heart Failure, 2015
- Ultrafiltration in Decompensated Heart Failure with Cardiorenal SyndromeNew England Journal of Medicine, 2012
- Diuretic Strategies in Patients with Acute Decompensated Heart FailureNew England Journal of Medicine, 2011